TP53 and glioma: Our findings uncover a TP53 variant at odds with LFS mutants in regard to breast cancer risk yet consistent with LFS mutants in predisposition to glioma and reveal an underlying mechanism of tissue-specific cancer susceptibility that is mediated by miRNAs.